Phase II study of neoadjuvant 5-FU + leucovorin + CPT-11 in patients with resectable liver metastases from colorectal adenocarcinoma

BACKGROUND: Following resection of liver metastases from colorectal cancer, 5-year survivals are reportedly 30 – 39%. It can be assumed that this clinical situation represents systemic disease. Therefore, it is postulated that systemic chemotherapy would improve outcomes, particularly in those whose...

Descripción completa

Detalles Bibliográficos
Autores principales: Bathe, Oliver F, Dowden, Scot, Sutherland, Francis, Dixon, Elijah, Butts, Charles, Bigam, David, Walley, Barb, Ruether, Dean, Ernst, Scott
Formato: Texto
Lenguaje:English
Publicado: BioMed Central 2004
Materias:
Study Protocol
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC476737/
https://www.ncbi.nlm.nih.gov/pubmed/15245580
http://dx.doi.org/10.1186/1471-2407-4-32

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC476737/
https://www.ncbi.nlm.nih.gov/pubmed/15245580
http://dx.doi.org/10.1186/1471-2407-4-32

Ejemplares similares